CD80 and neoplasm: Sui et al. [128] analyzed scRNA-seq data from MSI-H CRC patients and discovered that neutrophils interacted with CD8+ T cells in the tumor via the CD80/CD86-CTLA4 axis, contributing to local inflammation that predicted an unfavorable response to ICB.